Marina Faedi
Bolzano, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Correction to: Efficacy of initial temozolomide for high‑risk low grade gliomas in a phase II AINO (Italian Association for Neuro‑Oncology) study: a post‑hoc analysis within molecular subgroups of WHO 2016.
Journal: Journal of neuro-oncology
Published: November 07, 2019
Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016.
Journal: Journal of neuro-oncology
Published: July 04, 2019
Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.
Journal: The oncologist
Published: July 23, 2018
Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial.
Journal: The Lancet. Oncology
Published: July 12, 2018
Correction to: Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study.
Journal: Journal of neuro-oncology
Published: November 11, 2017
Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer.
Journal: Cancer chemotherapy and pharmacology
Published: October 13, 2016
Multiple primary tumors in a family with Li-Fraumeni syndrome with a TP53 germline mutation identified by next-generation sequencing.
Journal: The International journal of biological markers
Published: July 12, 2016
Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study.
Journal: Journal of neuro-oncology
Published: December 24, 2015
Defining the cutoff value of MGMT gene promoter methylation and its predictive capacity in glioblastoma.
Journal: Journal of neuro-oncology
Published: October 29, 2015
Hydroxyurea with or without imatinib in the treatment of recurrent or progressive meningiomas: a randomized phase II trial by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
Journal: Cancer chemotherapy and pharmacology
Published: September 11, 2015
Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma.
Journal: Neuro-oncology
Published: April 30, 2015
Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology).
Journal: Journal of neuro-oncology
Published: April 29, 2015
Last Updated: 09/26/2026